ANTI-EGFR ANTI-TREATMENT TREATMENT BY ANTIBODIES THAT HAVE LOW FOOCOSYLING

摘要

This invention relates to the field of cancer therapy using anticancer antibodies. Medical use of anti-EGFR antibodies having improved glycosylation characteristics, in particular reduced fucosylation, which demonstrate anti-cancer efficacy and an improved profile of undesirable side effects, is provided.